Rheumatology

Bringing hope with new therapies

Patients with rheumatic disease often deal with chronic conditions impacting daily activities. The need for new therapies is high. Each clinical trial brings hope of effective disease management. Our experienced team is here to support.

Rheumatology Expertise

Comprised of board-certified rheumatologists (adult and pediatric), and dedicated experts in operational strategy and execution. Since 2011, IQVIA has conducted > 320 rheumatology trials for lupus, rheumatoid arthritis, osteoarthritis, spondyloarthritis, gout, systemic sclerosis, Sjogren's Syndrome, and other rare rheumatic diseases. We understand your challenges – and are driving innovation to accelerate recruitment and improve data quality to help you bring new therapies to the patients that need them.

Transform your Rheumatology trials

Rheumatology clinical trials face challenges from low patient recruitment to high placebo response rates and complex endpoint data. With the power of IQVIA Connected Intelligence, we put therapeutic expertise, innovation and actionable insights into solutions to increase predictability and speed. This approach helps you meet milestones faster to bring new therapies to waiting patients.

ARTICLE
Disruptive Factors Shape RA Landscape
As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Solutions you may be interested in

Contact Us